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Echinococcus spp. Tapeworms
in North America
Jacey Roche Cerda, Danielle Elise Buttke, Lora Rickard Ballweber

Alveolar and cystic echinococcosis are emerging and reemerging in Europe, Africa, and Asia. The expansion of
Echinococcus spp. tapeworms in wildlife host reservoirs appears to be driving this emergence in some areas. Recent
studies suggest a similar phenomenon may be occurring in
North America. We describe the context of Echinococcus
spp. research in North America, with a specific focus on the
contiguous United States. Although studies were conducted
in the United States throughout the 1900s on various sylvatic and domestic Echinococcus spp. tapeworm cycles,
data are lacking for the past ≈30 years. We review previous
research, provide analysis of more recent focal studies, and
suggest that Echinococcus spp. tapeworms, in particular E.
canadensis, may be underrecognized. As a result, we suggest that additional research and surveillance be conducted
for these tapeworms in wildlife host reservoirs across the
United States.

E

chinococcus spp. (family Taeniidae, class Cestoda) are
zoonotic tapeworms currently infecting 2–3 million
persons worldwide and causing US $200–$800 million in
annual economic losses related to human infection (1,2).
Infection appears to be increasing, reemerging, and geographically expanding in multiple locations across Europe,
Asia, Africa, and the Americas (primarily in Latin America), with >200,000 new cases/year (3). Echinococcus spp.
tapeworms have complex domestic and sylvatic life cycles
that affect the health of >40 companion animal, livestock,
and wildlife host species (4,5).
The basic Echinococcus spp. life cycle involves 2
hosts, where carnivores (wild and domestic) are the definitive hosts and small mammals and ungulates (domestic and
wild) are the intermediate hosts (6). From within the small
intestine of the definitive host, the mature tapeworm releases immediately infective eggs that are shed with the feces
into the environment. Intermediate hosts ingest the eggs as
they feed on contaminated vegetation. Once ingested, the
oncosphere hatches and penetrates the small intestine to
migrate to various organs and tissues, where it develops
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into one or more hydatid cysts (6). Definitive hosts ingest
the cysts when feeding on the viscera of infected intermediate hosts (6). Humans are aberrant dead-end hosts that are
infected from accidental ingestion of eggs, typically from
interaction with domestic dogs, which act as bridge hosts
between wildlife and the human environment. Contamination of the human environment may occur either directly
(from feces) or indirectly (eggs carried on paws and fur)
(7). Humans may also become infected through foodborne
transmission, most often through eating inadequately
washed fruits and vegetables (8). Intermediate hosts and
humans may develop alveolar, cystic, or polycystic echinococcosis, depending on the parasite species involved (6).
Infection in livestock can cause substantial economic
losses, including the condemnation of infected viscera;
decreased meat, milk, and wool production; and delayed
fecundity, growth, and performance (4). Estimated global
economic loss due to infection in production animals is US
$1.5–$2 billion annually (2). The global disease burden on
wildlife species is unknown, as is the effect that echinococcosis may have on the overall fitness of wildlife animals
and populations.
Throughout the early decades of the 1900s, only 1
species of Echinococcus, E. granulosus, was formally recognized in North America and across the world. Analysis
of genetic and phenotypic data, host specificity and preference, and differences in human pathogenicity and tissue
tropism has since revealed that E. granulosus sensu lato is
actually composed of a complex of 10 specific genotypes,
G1–10 (9). Subsequently, several of the genotypes or genotype complexes have been elevated to distinct species: E.
granulosus sensu stricto (G1–G3), E. equinus (G4), E.
ortleppi (G5), E. intermedius (G6–G7), and E. canadensis (G8–G10) (9,10). Genotypes 6–7 are still often grouped
with E. canadensis; however, distinct host preferences and
genetics demonstrate the proper elevation to their own species (10). Additional recognized species of Echinococcus
are E. shiquicus, E. vogeli, E. felidis, E. oligarthra, and
E. multilocularis. E. granulosus sensu stricto and E. multilocularis tapeworms cause the 2 most pathogenic forms
of disease in humans; E. multilocularis infections are the
most deadly, given the metastatic nature of the cysts and
the related difficulty of treatment.
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Although well studied globally, the current presence,
prevalence, and transmission dynamics of Echinococcus
spp. tapeworms in the contiguous United States are currently unknown. Substantial research was conducted between
the early 1930s and the 1980s; however, very little research
has occurred in the past 3 decades. Given the documented
expansion of these tapeworms across many regions of the
world, including within Canada, a better understanding of
the presence, prevalence, and disease ecology in the United
States is needed, particularly because echinococcosis is not
a reportable disease. Additional research will provide scientists, veterinary and human medical professionals, and
other public health officials with a more complete picture
of Echinococcus spp. cycles in the United States. Here we
set the context for additional research through a synopsis of
Echinococcus spp. and echinococcosis in humans in North
America, with a focused discussion of endemic US Echinococcus spp. cycles from the early 1900s to the present. We
conclude with recommendations for further research.
Echinococcus spp. Tapeworms and
Echinococcosis in Alaska and Canada
Even before advances in molecular genetics, researchers recognized the form of E. granulosus cycling between
wild canids and their ungulate prey species in Alaska and
Canada as distinct and referred to it as the northern biotype (11). The northern biotype species is now recognized
as E. canadensis. In the boreal regions of North America,
E. canadensis are ubiquitous parasites of wild canids and
ungulates from the western coast of Alaska through all territories and provinces of Canada, exclusive of its east coast
(11–13). Caribou (Rangifer tarandus), moose (Alces alces), and elk (Cervus canadensis) appear to be the most important intermediate hosts, although other ungulate species
may become infected. Wolves (Canis lupus) and domestic dogs are the most important definitive hosts; however,
coyotes (Canis latrans) are also competent (11). Rausch’s
(11) comprehensive review of E. canadensis tapeworms
provides extensive information regarding the strongly endemic cycles he and others observed from the 1950s to the
late 1990s throughout Alaska, Canada, and other Arctic
countries. Likewise, readers are directed to Schurer et al.’s
(14,15) reviews of ungulate and wolf infections.
All 3 reviews indicate fairly stable E. canadensis
cycles and transmission dynamics in the Arctic and subArctic regions of North America. For example, Rausch reported that in a randomly collected sampling of 200 wild
canids in the Brooks Range of Alaska, ≈30% were infected
with E. canadensis tapeworms. This finding is similar to
Schurer et al.’s (15) recent report indicating infections in
37% (71/191) of wolves sampled across Canada. Rausch
(16) found 24% (24/101) of moose infected in an agricultural region of southern Alaska, and 4% (1/23) of moose

infected in the Anchorage area. Schurer et al.’s (14) review
of ungulate infections in Canada revealed prevalence of
0%–73% in elk, 1–21% in caribou, 11–38% in moose, and
0.3%–44% in white-tailed deer (Odocoileus virginianus),
depending on sample location.
E. multilocularis tapeworms are similarly endemic
in Alaska and Canada, spanning from the northern Arctic
regions south into the rural and urban southern provinces
of Canada, where urban coyotes and domestic dogs have
been confirmed as both definitive and aberrant intermediate
(dog) hosts (7,13,17,18). As with E. canadensis, Rausch
et al. (19) performed important work related to E. multilocularis in Alaska, with a particular focus on St. Lawrence
Island. Their work revealed heavy infections in Arctic fox
(Vulpes lagopus) and their small mammal prey species.
The mean rate of infection for 1,579 fox examined was
77%, whereas infection in prey animals could range from
10% to 80% (19). On St. Lawrence Island, dog necropsies
also revealed a 12% prevalence of infection (20).
Gesy et al.’s (21) recent review of E. multilocularis
tapeworms across Canada demonstrated coyotes, red fox
(Vulpes vulpes), wolves, and Arctic fox were all competent hosts, with prevalence differences related to sampling
location. For example, their report indicated 37% (10/27)
of coyotes and 17% (1/6) of red fox were infected in Quesnel, British Columbia (21). Three dogs in Canada were
also recently found to be infected with cysts (7,13,17). The
high prevalence in wild hosts along with the new intermediate infections in urban pet dogs has increased concern
that the geographic reach of E. multilocularis tapeworms is
expanding within Canada. As a result, Massolo et al. (22)
suggest that much more research is necessary to understand
potential public health risks associated with alveolar echinococcosis (AE) in North America.
Both AE and cystic echinococcosis (CE) have been
reported in Alaska and Canada, with most infections occurring in Native American populations in Alaska. During
1940–1990, a total of 300 cases of CE were reported in
Alaskan Native Americans, with only an additional 3 cases
between 1990 and 1999 (23). Pathogenicity of CE in Native American patients appeared to be fairly benign, with
smaller, asymptomatic cysts that often resolved without the
need for surgery (23). However, Castrodale et al. (23) reported 2 unusually severe cases of CE in Alaska in 1999,
in a 51-year-old Caucasian woman and a 17-year-old Native Alaskan woman. The cysts from the latter patient were
confirmed as belonging to the species E. canadensis (G8)
(23). Most AE cases in Alaska also arose in Native American populations, with St. Lawrence Island as an infection
hotspot. Jenkins et al. (13) reported 54 human cases during
1947–1986, none during 1986–2010, and potentially 5 during 2010–2014, although the latter infections were more
likely to be CE.
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Human AE and CE cases in Canada are much less
prevalent than those in Alaska. Serosurveillance of indigenous populations in the Saskatchewan, Nunavut,
Quebec, and the Northwest Territories of Canada indicated exposure to CE of 0%–48% (20). CE infections in
nonindigenous patients are rare and often only incidentally reported. AE cases in Canada are even more rare,
with 1 autochthonous case reported before 2013 (20).
Subsequent reviews have found 12–16 additional cases;
however, Deplazes et al. (20) suggest these numbers are
under representative, given the strongly endemic regions
present in Canada.
Echinococcus spp. Tapeworms and
Echinococcosis in Mexico
Far fewer studies have researched the Echinococcus spp.
tapeworms present in Mexico; however, the primary species appears to be E. intermedius (G7), cycling between
dogs and pigs (20). The species E. granulosus s.s. (G1) and
E. ortleppi (G5) were also previously reported (20). Prevalence in slaughtered pigs is low, with reports of 0.27%–
6.5%. Deplazes et al. (20) provide more extensive information regarding infections in Mexico.
Echinococcus spp. Tapeworms and CE
in the Contiguous United States
Domestic Cycles

Historically, several genotypes of E. granulosus s.l. tapeworms were considered endemic and regularly cycling in
the Mississippi Valley, the mid-Atlantic states, and multiple western and southwestern states. Franklin and Ward
(24) reported that hydatid cysts were found in hogs and cattle in Virginia, Oklahoma, Arkansas, and Louisiana before
1951. They then reported the first discovery in Mississippi,
finding that 2 of the 50 dogs they examined in 1951 were
infected with E. granulosus s.l. tapeworms. Subsequently,
Ward (25) reported that 6% of 8,066 slaughtered hogs in
Mississippi were infected in 1956 and that 4 of the 9,300
dog intestines he examined over 8 years were infected with
300–700 adult E. granulosus cestodes each. At that time, 15
dogs had been confirmed with E. granulosus infection, with
5 of them from Mississippi (25). Given our current genetic
understanding of Echinococcus spp., the species cycling
in Mississippi was most likely E. intermedius (G7). Infections were also reported in dogs from New York, Kentucky,
Georgia, and Tennessee, as well as Washington, DC (25).
However, we were unable to find the originally cited papers
to report the intermediate hosts involved and thus cannot
comment on what species were present in those states.
Throughout the 1900s, an endemic dog/sheep cycle of
CE also existed in the Central Valley of California. Through
examination of the organs of 22,720 sheep carcasses during
232

December 1967–June 1968, Sawyer et al. (26) found 1,100
infected sheep. Tracebacks conducted where possible demonstrated that infections could range from 5% to 99% of
a producer’s entire herd (26). Some of the infected herds
originated in Idaho and Utah, while the rest originated from
8 ranches in 4 California counties (26). For the producers
with the highest herd prevalence, Sawyer et al. (26) investigated the ranches, took medical histories of the families,
tested the onsite dogs for taeniids through arecoline purging, and tested live sheep serum for evidence of infection.
Resident domestic dogs and sheep were infected on 3 of
the 4 ranches evaluated, implying local transmission. Local
transmission indicates that the dogs were probably allowed
to consume viscera of infected sheep, with subsequent egg
contamination of the human environment through dog infections (27). Across the same 4 ranches, 3 humans also
harbored hydatid cysts; however, only 1 of these cases was
confirmed as acquired within California.
In Utah, Loveless et al. (28) investigated dog and sheep
infections during 1971–1976, finding an overall prevalence
of 11.3% (95/839) in dogs and 9.8% (877/8,994) in sheep. A
subsequent study by Anderson et al. (29), with data covering
1971–1982, revealed a prevalence of 9.7% (109/1,120) in
dogs and 7.1% (1,116/15,775) in sheep. During 1944–1980,
Utah had the highest density of autochthonous human cases
in the United States, with 50 persons infected (28). A similar
dog/sheep cycle was established in New Mexico and Arizona
(30). In those areas, human infections were reported during
1969–1976, revealing 21 confirmed autochthonous cases.
Nineteen of the cases occurred in Native Americans of the
Navajo, Zuni, and Santo Domingo tribes (30). The source of
infection in all of these areas appeared to be contamination
of the human environment by infected dogs. Risk factors for
human infection included sheepherding behavior; companion-animal ownership; home slaughter of sheep; allowing
dogs to consume raw viscera; and contact with dogs, sheep,
and swine (31,32). Although not confirmed, our current understanding of Echinococcus spp. tapeworms suggests that
the organism causing the California, Utah, New Mexico, and
Arizona cycles was most likely E. granulosus s.s.
More recent focal studies have revealed that cycles of
E. granulosus s.l. continue to occur throughout the United
States. For example, in 1994, Hoberg et al. (33) reported
an unusual case of 3 cysts in a 14-year-old Thoroughbred
horse that lived in Virginia and Maryland. The cysts were
not sequenced to determine the genotype; however, those
authors assert it was probably related to the species E. equinus (G4), as previously found in horses in Europe and Asia.
Sylvatic Cycles

Throughout the mid-1900s to late 1900s, a sylvatic coyote/
deer cycle occurred concurrently with the domestic sheep/
dog cycle in California (34,35). Brunetti and Rosen (34)
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analyzed 2,049 deer carcasses collected between 1945–
1969 and found an overall infection rate of 1.3%. The infected animals were concentrated in 8 counties in the Central
Valley of California. Although unknown, the species involved in the sylvatic cycle may have been E. canadensis
given the host species involved.
Riley (36) reported a sylvatic cycle between moose
and wolves in Minnesota in the 1930s. Ramsey (37) reported that E. canadensis infection was found in a moose in
northwestern Montana during 1976–1983. In 2009, Foreyt
et al. (38) reported the presence of E. canadensis infections
in wolves, elk, mule deer (Odocoileus hemionus), and a
mountain goat (Oreamnos americanus) in Idaho and Montana; however, the specific genotypes (G8 or G10) were not
delineated. In 2012, Lichtenwalner et al. (39) described the
finding of an E. canadensis (G8)–infected moose in Maine.
The several sylvatic cycles reported in California,
Montana, Idaho, and Minnesota indicate that E. canadensis
tapeworms have been sporadically endemic in wild canid/
ungulate populations across the United States since the first
discovery in the early 1900s. With no further cases reported, the coyote/deer cycle appears to have ended in California. However, the cestode now appears to be reemerging in
a wolf/ungulate cycle in the western United States.
E. multilocularis and AE in the Contiguous
United States
E. multilocularis tapeworms are also historically endemic
in several northern states. During 1965–1969, Leiby et al.
(40) examined 7,898 definitive and intermediate host mammals from eastern Montana, North and South Dakota, Minnesota, and Iowa. Among the definitive hosts, the authors
found that 8.5% (131/1,540) of red fox and 4.1% (7/171) of
coyotes examined were infected. In North Dakota, 55.3%
of red fox were found infected in 1965, while only 7.3%
were infected in 1968. No domestic cats (n = 35) or dogs (n
= 88) were found to be infected (40). However, in a subsequent report, Leiby and Kritsky (41) reported that 2 adult
house cats from a homestead in North Dakota were infected
with E. multilocularis tapeworms in 1971.
Of the numerous potential intermediate hosts examined
by Leiby et al. (40), only 3 species, the deer mouse (Peromyscus maniculatus), meadow vole (Microtus pennsylvanicus), and house mouse (Mus musculus), were found to
have E. multilocularis cysts. Infected deer mice were found
in all 5 states, with the highest number, 202/4,209 (4.8%),
in North Dakota. Infected meadow voles were found only
in Iowa and North Dakota, with 1.9% infected (20/1,033).
Only 1/91 (1.1%) house mice examined, also from North
Dakota, was infected. The reported infections may be an
overly conservative estimate because data were obtained
through visual examination of the carcasses for cysts; early
or latent cysts may be too small for gross visualization.

In the 1980s, Ballard et al. (42,43) extended the known
range of E. multilocularis tapeworms into Nebraska, Illinois, and Wisconsin, further indicating the endemic cycle
in the north-central United States. Ten (27%) of 36 foxes
were infected in Nebraska, 4 (10%) of 40 in Illinois, and
6 (8.3%) of 72 in Wisconsin (42). In the mid-1990s, the
known range expanded again when E. multilocularis infection was found in Michigan and Ohio (44,45).
In 2000, Hildreth et al. (46) reported the results of a
combined study of both wild canids and human trappers
in South Dakota. The intestines of foxes trapped between
1987–1991, and of coyotes trapped between 1990–1991,
were examined for the presence of E. multilocularis tapeworms. Results showed that 74.5% of foxes and 44.4% of
coyotes were infected at the time of trapping. Because trappers are a population at extreme risk for AE, given their
constant and extended contact with potentially infected
wild canids, blood samples were obtained from 115 attendees of the South Dakota trappers meetings in 1990 and
1991. However, despite their high risk, none of the trappers
showed evidence of infection.
Only 1 autochthonous case of AE has been confirmed in
the contiguous United States, and that occurred in a 56-yearold woman from Minnesota (47). The patient had never lived
outside of Minnesota, and her travel history included only
California, Hawaii, Florida, and Manitoba, Canada. Gamble
et al. (47) asserted that she was most likely to have been infected through interaction with pet dogs allowed to consume
rodents on the farm where she grew up.
Conclusions and Recommendations
In the past 3 decades, there has been little focus on Echinococcus spp. tapeworms in the contiguous United States in
humans or animals. The apparent lack of concern regarding
the potential public health threat posed by echinococcosis
is probably due to the rarity of reported human cases. Similarly, since the 1980s, there have only been a handful of reports on the presence and prevalence of Echinococcus spp.
tapeworms in domestic and wild animals in the lower 48
states. The lack of human cases may reflect low exposure
to infected definitive hosts of either domestic or sylvatic
origin. Alternatively, it may reflect lack of detection, misdiagnosis, or failure to publish literature regarding new AE
and CE cases. Regardless of the reason, however, there is a
legitimate concern that the public health risk may increase
within the United States in the future, given the continued
expansion of human infection in Europe and Asia, as well
as an apparent expansion of the range of E. multilocularis
tapeworms in Canada.
Current surveillance and basic scientific understanding of Echinococcus spp. tapeworms and echinococcosis in
the United States is particularly lacking. In addition, there
are many outstanding questions, including the presence,
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prevalence, and geographic distribution of Echinococcus
spp. tapeworms across the contiguous United States; geospatial, ecologic (both biotic and abiotic), and host population variables influencing sylvatic echinococcosis dynamics; and perhaps most important, what risk these sylvatic
and domestic cycles pose to human health. As noted by
Massolo et al. (22), Canada appears to be experiencing an
increase in the presence and prevalence of E. multilocularis
tapeworms, with spillover events starting to occur. If this
asserted expansion is true, a similar expansion may be occurring in the United States. We support increased surveillance of Echinococcus spp. tapeworms in the United States
to answer these questions and in particular to focus on the
existing and potential public health risks associated with
endemic Echinococcus spp. tapeworms. To enhance data
collection on current and past cases, and further define the
human burden of echinococcosis, we support and recommend the use of historically underused data sources, such as
the National Inpatient Sample (48). We believe addressing
the described data gaps is very important not only because
of potential spillover from sylvatic cycles but also because
echinococcosis is not reportable in either animals or humans
in the United States and the United States does not screen for
these types of infections in imported animals. If appropriate
surveillance occurs that comprehensively analyzes current
endemic cycles, then effective and efficient detection of
new or expanding cycles or spillover events would be much
more likely to occur, leading to a decrease in potential human cases or other negative public health outcomes.
About the Author
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